Express Pharma

September 16-30, 2012

ArchiveCover Story

By On Sep 17, 2012

Open publication – For Past Issues

Prev Post

Glenmark Pharmaceuticals initiates phase II study of GBR 500 for Ulcerative Colitis

Next Post

ABLE, DUKE and OSHL conduct workshop on Meeting the Challenges of Developing New Anticancer Therapies

Leave A Reply